Form 4: Daxor Corp: CEO Acquires Shares
Insider Transaction Filing
Daxor Corp CEO Michael Feldschuh acquired 1,000 shares of common stock.
Summary
- Michael Feldschuh, CEO and Director of Daxor Corp, acquired 1,000 shares of common stock on April 8, 2026.
- The acquisition was made at a price of $9.07 per share.
- Following this transaction, Mr. Feldschuh beneficially owns 213,694 shares of Daxor Corp common stock directly.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a moderately positive development due to the CEO's acquisition of shares, signaling confidence, though the transaction size is relatively small compared to his total holdings.
Positives
- Insider buying by the CEO can signal confidence in the company's future prospects.
- The CEO's direct ownership of a significant number of shares (213,694) indicates a strong alignment of interests with other shareholders.
Future Outlook
No specific forward-looking statements or guidance were provided in this filing.
Industry Context
StockSavvy.ai notes that insider transactions, particularly by C-suite executives, are closely watched by the market as potential indicators of a company's health and future performance. This acquisition by the CEO of Daxor Corp could be interpreted as a positive signal.
Stakeholder Impact
- Shareholders: May view the CEO's purchase as a positive signal of confidence in the company's future, potentially influencing investment decisions.
- Employees: The CEO's investment could reinforce employee confidence in the company's stability and growth prospects.
- Management: Demonstrates commitment and alignment of interests with shareholders.
Key Dates
| Date | Description |
|---|---|
| 04/08/2026 | Transaction Date for acquisition of Daxor Common Stock by Michael Feldschuh. |
| 04/08/2026 | Date of filing of the Form 4 statement. |
Recommendation
holdThe acquisition of shares by the CEO is a positive signal, suggesting confidence in the company's future. However, without broader financial performance data or strategic updates, a 'hold' recommendation is prudent, allowing for further analysis of the company's overall health and market position.
Keywords
Daxor Corp, DXR, Insider Trading, Stock Acquisition, CEO, Beneficial Ownership, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.